UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.

Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20

Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends

Alfa Chemistry Unveils Its Range of Dietary Supplements: Fruit Juice Powder, Enzyme Powder, and Probiotics Product

In recent years, the demand for dietary supplements has been on the rise as more and more individuals seek to maintain a healthy lifestyle. Alfa Chemistry, a renowned chemical supplier, has unveiled its selection of dietary supplements, offering consumers a wide range of options to support their nutritional needs. With its new product line, including Fruit Juice Powder, Enzyme Powder, and Probiotics Product, Alfa Chemistry aims to provide natural and effective solutions for various health concerns.

Validated AI-Driven Target Identification and Biomarker Discovery with Insilico Medicine’s PandaOmics

PandaOmics is a cloud-based software platform from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine that helps researchers identify therapeutic targets and discover new biomarkers in order to select the most promising targets to pursue based on all available data and pre-existing research. A new paper in the Journal of Chemical Information and Modeling provides definitive validation of this software platform.

AVIA’s Generative AI Strategic Collaborative Highlights Six-Month Milestones And Outlines Next Steps For Pioneering Initiative

From Simple Dressings to Smart Technology: The Rise of Smart Bandages in the Healthcare Landscape

Driven by the rise of chronic wounds, particularly those linked to diabetes, the healthcare industry sees a surge in innovative smart bandages. These advanced dressings offer faster healing, infection control, and real-time monitoring compared to traditional methods.

Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products

Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics

Matexcel Enlarged Its Offerings for Pure Metal Powders for Research Use

Creative BioMart Launches Protein-Lipids-Nucleic Acid Interaction Assay and Screening Services

25m Health Partners with Clearwater to Develop a Scalable Cybersecurity and Compliance Program Across its Portfolio

Profacgen Launches Fluorescence Polarization Assay for Advanced Protein Interaction Analysis

BioIVT Announces Expansive Fresh Leukopak Capability in Europe

Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award

Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award

Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024

Sunbird Bio announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024.

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma offer Semaglutide Side Chain AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).